These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


379 related items for PubMed ID: 18163264

  • 1. [Thorough clarification of national health insurance statistics. This prevents regress actions].
    Thomas A.
    MMW Fortschr Med; 2007 Nov 29; 149(48):56-7. PubMed ID: 18163264
    [No Abstract] [Full Text] [Related]

  • 2. [You must prescribe in a "cost-effective" manner. Lawyers have little understanding for this].
    Ulsenheimer K.
    MMW Fortschr Med; 2007 May 10; 149(19):56. PubMed ID: 17668795
    [No Abstract] [Full Text] [Related]

  • 3. [The physician caught between two chairs. Comments on the difficulty in dealing with off-label use].
    Harder Yv.
    Urologe A; 2007 Oct 10; 46(10):1429-34. PubMed ID: 17786403
    [No Abstract] [Full Text] [Related]

  • 4. [Collective regress should disappear. And then testing that beams can bend].
    MMW Fortschr Med; 2001 Feb 22; 143(8):45-6. PubMed ID: 11265541
    [No Abstract] [Full Text] [Related]

  • 5. [Who will save general practitioners?].
    MMW Fortschr Med; 2006 May 04; 148(18):47. PubMed ID: 16736691
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Drug costs should be lower. Hessian colleagues beaten without compassion].
    MMW Fortschr Med; 2004 Jul 08; 146(27-28):49. PubMed ID: 15526667
    [No Abstract] [Full Text] [Related]

  • 9. [Regulation for improving economics in drug treatment].
    Holstein L, Koch B.
    Chirurg; 2006 Jul 08; Suppl():214-6. PubMed ID: 17855869
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [New institute for additional drug evaluation. Do we really need another barrier?].
    Schmidt K.
    MMW Fortschr Med; 2003 Jul 24; 145(29-30):55-6. PubMed ID: 12958781
    [No Abstract] [Full Text] [Related]

  • 12. [Legal dispute about the black drug list. Irrespective of positive or negative list--I am in favor].
    Thöns M.
    MMW Fortschr Med; 2006 Oct 05; 148(40):8. PubMed ID: 17338085
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [GMG proposal for non-prescription medications. Expensive cost savings].
    MMW Fortschr Med; 2004 Aug 05; 146(31-32):48. PubMed ID: 15529713
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Drug prescribing in practitioner networks--improved treatment at no extra cost?].
    Wunder S, Brune K.
    MMW Fortschr Med; 2004 Dec 16; 146(51-52):43-4. PubMed ID: 15675244
    [No Abstract] [Full Text] [Related]

  • 18. [More income, fewer expenses. Family physician and economist Dr. Riedl demonstrates how he does it (interview by Anke Thomas)].
    Thomas A.
    MMW Fortschr Med; 2005 Nov 17; 147(46):62-3. PubMed ID: 16358640
    [No Abstract] [Full Text] [Related]

  • 19. [Only what happens in your own practice counts. No fear of collective regress].
    Schmidt KA.
    MMW Fortschr Med; 2000 Nov 02; 142(44):47. PubMed ID: 11107807
    [No Abstract] [Full Text] [Related]

  • 20. [Can physicians really save still more in drug prescriptions?].
    Schmidt K.
    MMW Fortschr Med; 2006 Feb 02; 148(5):44-5. PubMed ID: 16518938
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.